Your firm's quality unit's oversight of your GMP manufacturing and laboratory operations is inadequate.
Inspection Record
Biocon Sdn. Bhd. — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Your bateh record documentation practices are inadequate.
There is a lack of assurance that your cleaning procedures, used for non-product-contact process equipment in the RABS, is validated to prevent contamination, Specifically, A.
There is lack ofassurance that water and@/@)) sed in the manufacture ofOG rug substance manufacturing processes is suitable for its intended use.
A record as of the US FDA document published on 2025-06-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.